Change search
ReferencesLink to record
Permanent link

Direct link
L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles
Show others and affiliations
2016 (English)In: Small, ISSN 1613-6810, E-ISSN 1613-6829, Vol. 12, no 3, 301-306 p.Article in journal, Letter (Refereed) PublishedText
Abstract [en]

Manganese oxide nanoparticles (MONPs) are capable of time-dependent magnetic resonance imaging contrast switching as well as releasing a surface-bound drug. MONPs give T2/T2* contrast, but dissolve and release T1-active Mn2+ and l-3,4-dihydroxyphenylalanine. Complementary images are acquired with a single contrast agent, and applications toward Parkinson's disease are suggested.

Place, publisher, year, edition, pages
2016. Vol. 12, no 3, 301-306 p.
National Category
Cancer and Oncology
URN: urn:nbn:se:umu:diva-116741DOI: 10.1002/smll.201502545ISI: 000368707800003PubMedID: 26619158OAI: diva2:904821
Available from: 2016-02-19 Created: 2016-02-11 Last updated: 2016-02-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Sandvig, Axel
By organisation
Department of Pharmacology and Clinical Neuroscience
In the same journal
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 25 hits
ReferencesLink to record
Permanent link

Direct link